361 related articles for article (PubMed ID: 20797646)
21. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
[TBL] [Abstract][Full Text] [Related]
22. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
[TBL] [Abstract][Full Text] [Related]
23. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128
[TBL] [Abstract][Full Text] [Related]
24. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM
PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621
[TBL] [Abstract][Full Text] [Related]
25. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
[TBL] [Abstract][Full Text] [Related]
26. Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign.
Halpin AL; Gu W; Wise ME; Sejvar JJ; Hoekstra RM; Mahon BE
Epidemiol Infect; 2018 Oct; 146(13):1740-1745. PubMed ID: 29986777
[TBL] [Abstract][Full Text] [Related]
27. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré syndrome and influenza virus infection.
Sivadon-Tardy V; Orlikowski D; Porcher R; Sharshar T; Durand MC; Enouf V; Rozenberg F; Caudie C; Annane D; van der Werf S; Lebon P; Raphaël JC; Gaillard JL; Gault E
Clin Infect Dis; 2009 Jan; 48(1):48-56. PubMed ID: 19025491
[TBL] [Abstract][Full Text] [Related]
30. Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?
Nelson KE
Am J Epidemiol; 2012 Jun; 175(11):1129-32. PubMed ID: 22582208
[TBL] [Abstract][Full Text] [Related]
31. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW
Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209
[TBL] [Abstract][Full Text] [Related]
32. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
Andrews N; Stowe J; Al-Shahi Salman R; Miller E
Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631
[TBL] [Abstract][Full Text] [Related]
33. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
[TBL] [Abstract][Full Text] [Related]
34. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
[TBL] [Abstract][Full Text] [Related]
35. Guillain-Barré syndrome following influenza vaccination.
Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
[TBL] [Abstract][Full Text] [Related]
36. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
[TBL] [Abstract][Full Text] [Related]
37. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England.
Tam CC; O'Brien SJ; Rodrigues LC
Emerg Infect Dis; 2006 Dec; 12(12):1880-7. PubMed ID: 17326939
[TBL] [Abstract][Full Text] [Related]
38. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
[TBL] [Abstract][Full Text] [Related]
39. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
Choe YJ; Cho H; Bae GR; Lee JK
Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
[TBL] [Abstract][Full Text] [Related]
40. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
Tremblay ME; Closon A; D'Anjou G; Bussières JF
Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
